Jin Takasaki
Overview
Explore the profile of Jin Takasaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
709
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Terada-Hirashima J, Suzuki M, Tsujimoto Y, Hamamoto Y, Uemura Y, Tsushima K, et al.
Drug Discov Ther
. 2022 Oct;
16(5):225-232.
PMID: 36288939
The aim of this study was to determine the efficacy and safety of ciclesonide in the treatment of novel coronavirus disease 2019 (COVID-19) as gauged by pneumonia progression. This multi-center,...
22.
Lee S, Aung M, Kawatsu L, Uchimura K, Miyahara R, Takasaki J, et al.
Int J Environ Res Public Health
. 2022 Oct;
19(19).
PMID: 36231897
This study aimed to describe characteristics and treatment outcomes of overseas-born pulmonary tuberculosis (PTB) patients in Japan, and identify the factors associated with "treatment non-success". We conducted a retrospective analysis...
23.
Suzuki M, Hayakawa K, Asai Y, Matsunaga N, Terada M, Ohtsu H, et al.
Jpn J Infect Dis
. 2022 Mar;
75(4):419-422.
PMID: 35228500
The detection of other pathogens in patients with hospitalized coronavirus disease (COVID-19) are not frequent. Considering that data from Japan are limited, we conducted an observational study including patients with...
24.
Morishita M, Suzuki M, Matsunaga A, Ishizhima K, Yamamoto T, Kuroda Y, et al.
J Infect Chemother
. 2022 Feb;
28(7):971-974.
PMID: 35184976
Corticosteroids are widely used to treat severe COVID-19, but in immunocompromised individuals, who are susceptible to persistent infection, long term corticosteroid use may delay viral clearance. We present a case...
25.
Uchihara M, Bouchi R, Kodani N, Saito S, Miyazato Y, Umamoto K, et al.
J Diabetes Investig
. 2022 Jan;
13(6):1086-1093.
PMID: 35075818
Aims/introduction: Diabetes is associated with poor clinical outcomes of coronavirus disease 2019 (COVID-19). However, the impact of newly diagnosed diabetes on prognosis has not been clarified. The objective of this...
26.
Yamaguchi Y, Hashimoto M, Saito S, Morita T, Tsukada A, Kusaba Y, et al.
Intern Med
. 2022 Jan;
61(6):913-916.
PMID: 34980790
A 33-year-old woman with a fever, cough, and pharyngitis was admitted after left-sided pleural effusion was detected. The fever and upper respiratory symptoms were confirmed, and she was diagnosed with...
27.
Morita C, Suzuki M, Izumi S, Tsukada A, Tsujimoto Y, Sakamoto K, et al.
Respir Investig
. 2021 Dec;
60(2):241-247.
PMID: 34872886
Background: Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2, has been a significant concern worldwide since its outbreak in December 2019. Various treatments are...
28.
Kalil A, Mehta A, Patterson T, Erdmann N, Gomez C, Jain M, et al.
Lancet Respir Med
. 2021 Oct;
9(12):1365-1376.
PMID: 34672949
Background: Functional impairment of interferon, a natural antiviral component of the immune system, is associated with the pathogenesis and severity of COVID-19. We aimed to compare the efficacy of interferon...
29.
Hikida S, Morioka S, Fujii N, Tajima T, Terayama Y, Sugiura Y, et al.
Glob Health Med
. 2021 Sep;
3(4):236-239.
PMID: 34532604
We investigated possible sources of newly infected patients with coronavirus disease (COVID-19) after the fourth wave in order to explore unknown sources. Retrospective chart review on all the confirmed patients...
30.
Nomoto H, Yamamoto K, Yamada G, Suzuki M, Kinoshita N, Takasaki J, et al.
J Infect Chemother
. 2021 Aug;
27(11):1669-1673.
PMID: 34454833
Introduction: The automated quantitative antigen test (QAT), which detects severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is suitable for mass screening. However, its diagnostic capability differentiated by time from onset...